Carbidopa and Levodopa (CREXONT)
Aromatic Amino Acid class · 0 generic manufacturers · 0 ANDAs filed at FDA.
Questions a plan sponsor actually asks.
What is Carbidopa and Levodopa used for?
Carbidopa and Levodopa is a Aromatic Amino Acid medication tracked in Medicare Part D.
Is there a generic for Carbidopa and Levodopa?
No. Carbidopa and Levodopa is brand-only with no generic equivalents currently in market.
How much does my plan pay for Carbidopa and Levodopa?
Across 329 Part D plans, Carbidopa and Levodopa averages $0.073/unit (NADAC). Lowest available: $0.072/unit. Highest in distribution: $0.073/unit.
Is Carbidopa and Levodopa on the FDA shortage list?
No. Carbidopa and Levodopa is not currently on the FDA Drug Shortage Database.
5 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.
Same class. Different math.
Sources · every number above traces back.
Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book · NADAC unit costs: CMS NADAC weekly file (20 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.